Código QR

Nonmotor Symptoms in Patients with PARK2 Mutations

Decreased 123I-meta-iodobenzylguanidine (MIBG) uptake in MIBG myocardial scintigraphy, olfactory dysfunction, and rapid eye movement (REM) sleep behavior disorder (RBD) are considered useful early indicators of Parkinson disease. We investigated whether patients with PARK2 mutations exhibited myocar...

Descrición completa

Gardado en:
Detalles Bibliográficos
Principais autores: Asako Yoritaka, Yumi Shimo, Yasushi Shimo, Yuichi Inoue, Hiroyo Yoshino, Nobutaka Hattori
Formato: Artigo
Idioma:Inglês
Publicado: Wiley 2011-01-01
Series:Parkinson's Disease
Acceso en liña:http://dx.doi.org/10.4061/2011/473640
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!